MATRIX BIOMED - Key Persons
Dr. Wilcox serves as the Chief of Nephrology and Hypertension, the Director of the Hypertension, Kidney and Vascular Research Center, and the Associate Director of the Angiogenesis Program at the Lombardi Center Institute at Georgetown University. He is also the Vice-Chair for Academic Affairs at the Department of Medicine and the George E. Schreiner Chair of Nephrology at Georgetown University School of Medicine. Dr. Wilcox's scientific research centers on studies of kidney and microvascular disease in hypertension. Supported by grants from the NIH, his research encompasses experiments on genes, cells and animal models, in addition to clinical research in patients with hypertension and kidney diseases. Dr. Wilcox is the author of more than 250 scientific articles and 2 books on nephrology and hypertension.
Job Titles:
- Vice President, Drug Development
Dr. Monaghan has extensive experience in development of new drugs in a wide variety of therapeutic areas. He has served as co-founder and Chief Development Officer of Thesan Pharma, Vice President of Drug Development at Kadmus Pharma, and Vice President of Clinical Development at TRF Pharmaceuticals. Earlier in his career, Dr. Monaghan held senior positions in drug development at Serono, Co-Census, and Allergan.
Job Titles:
- Chairman of Radiation Oncology at Cedars - Sinai Medical Center
Dr. Sandler serves as the Chair of Radiation Oncology at Cedars-Sinai Medical Center with affiliation at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. He is also the principal investigator for the National Radiation Therapy Oncology Group, focusing on radiology and chemotherapy for prostate cancer. Working with the National Institute of Health, Dr. Sandler has been involved in the investigation of innovative radiation strategies targeting prostate cancer and evaluating quality of life of prostate cancer patients following surgery and radiation therapy.
Job Titles:
- Assistant Professor at the University of Vancouver
Dr. Quandt serves as the Assistant Professor at the University of Vancouver, British Columbia, with affiliation at the Centre for Brain Health. Her research focuses on neuroinflammation in damage and repair relevant to multiple sclerosis and other nervous system disorders. Dr. Quandt's research applies molecular and cellular techniques in cell-based and disease models to determine the relative contributions of inflammatory cells and mediators to disease development. She also focuses on the identification of cyto-and neuroprotective pathways relevant to inflammatory and neurodegenerative disorders.
Mr. Smith has served in senior executive positions with a number of public and private biotechnology and pharmaceutical companies, all of which have been involved in the discovery and development of new drugs, in multiple therapeutic areas. He has been Chief Executive Officer and a director of Virolab, Inc., President, Chief Executive Officer and Director for Genelabs Technologies, Inc. (Nasdaq:GNLB) and Executive Director of Worldwide Business Development at ICN Pharmaceuticals, Inc. (NYSE:ICN), now known as Valeant Pharmaceuticals International.
Job Titles:
- Medical Director for Neurosurgery at Inovia Fairfax Hospital
Dr. Watson serves as the Medical Director for Neurosurgery at Inovia Fairfax Hospital in Fairfax, Virginia. He specializes in pituitary tumors, meningiomas, brain tumors, and spinal surgery. His expertise also includes cerebrovascular disease, trigeminal neuralgia, hemifacial spasm, Chiari malformation, spinal AVM's, spinal disorders, "brain bypass" surgery, von-Hippel-Lindau disease, and stereotactic radiation surgery.
Job Titles:
- Executive Director of UCI Medical Center 's H.H. Chao Comprehensive Digestive Disease Center
Dr. Chang serves as the Executive Director of UCI Medical Center's H.H. Chao Comprehensive Digestive Disease Center and as a Professor and Chief of the Division of Gastroenterology at the University of California Irvine. Dr. Chang's expertise includes developing novel mechanisms for arresting cancer growth, molecular mechanisms of gastrointestinal and esophageal ulcers, gene therapy for treating esophageal and pancreatic cancers, developing new techniques and modalities in interventional endoscopy, and diagnosis and treatment of hepatitis B and C, liver cancer and inflammatory bowel disease.
Job Titles:
- Assistant Professor at the University of Arizona
Dr. Gonzalez serves as the Assistant Professor at the University of Arizona in the Department of Radiation Oncology with affiliation at Banner-University Medical Center in Tucson, Arizona. His research includes investigation of novel techniques for whole breast radiotherapy and is a principal investigator in determining methods for improving intensity modulated radiation therapy following mastectomy. He specializes in treating patients with breast cancer, lymphoma and metastatic cancer.